Cargando…
Doxorubicin Inhibits Proliferation of Osteosarcoma Cells Through Upregulation of the Notch Signaling Pathway
Doxorubicin plays a major role in the treatment of osteosarcoma disorders. The Notch signaling pathway exerts various biological functions, including cell proliferation, differentiation, and apoptosis. In the present study, we investigated the effects of different doses of doxorubicin on proliferati...
Autores principales: | Ji, Peng, Yu, Ling, Guo, Wei-Chun, Mei, Hong-Jun, Wang, Xiao-Ju, Chen, Hu, Fang, Shuo, Yang, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cognizant Communication Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7838446/ https://www.ncbi.nlm.nih.gov/pubmed/26351207 http://dx.doi.org/10.3727/096504015X14343704124340 |
Ejemplares similares
-
Notch signaling is important for epithelial-mesenchymal transition induced by low concentrations of doxorubicin in osteosarcoma cell lines
por: Yang, Jian, et al.
Publicado: (2017) -
Pleiotrophin promotes chemoresistance to doxorubicin in osteosarcoma by upregulating P-glycoprotein
por: Wu, Dapeng, et al.
Publicado: (2017) -
Doxorubicin-induced novel circRNA_0004674 facilitates osteosarcoma progression and chemoresistance by upregulating MCL1 through miR-142-5p
por: Ma, Xiao-Long, et al.
Publicado: (2021) -
Inhibition of Notch pathway prevents osteosarcoma growth by cell cycle regulation
por: Tanaka, M, et al.
Publicado: (2009) -
Cisplatin selects for stem-like cells in osteosarcoma by activating Notch signaling
por: Yu, Ling, et al.
Publicado: (2016)